Human TNF-beta FlowCytomix Simplex

Also known as: Lymphotoxin-alpha, TNF superfamily member 1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS8202FF*

Cat. No. Size
BMS8202FF 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human TNF-beta FlowCytomix Simplex.

Click on image to view more information.

  • Data for Human TNF-beta FlowCytomix Simplex.
Description

Description: This FlowCytomix Simplex Kit is designed for the measurement of Human TNF-beta in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Human Basic Kit (cat. BMS8420FF), this kit can be used to detect TNF-beta alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population B10.

TNF-beta is produced by activated lymphocytes, whereas TNF-alpha is mostly produced by activated macrophages. Soluble TNF-beta is a T-cell derived glycoprotein of 25 kD encoded by a gene within the MHC. The molecule consists of a 17.5 to 18 kD polypeptide core and 7kD of N-linked carbohydrate. TNF-beta is 28% structurally homologous with the macrophage produced non-glycoprotein TNF-alpha.

TNF-beta is induced in an antigen-specific MHC restricted fashion from class I and class II restricted T cells. Viral infection is also associated with TNF-beta production by lymphoid cells. TNF-beta has several effects on target cells including killing, growth stimulation, induction of adhesion molecule (ICAM-1) expression, and induction of differentiation. The mechanisms of TNF-beta effects involve receptor binding and internalization and several sequelae including changes in prostaglandins and chromosome integrity. TNF-beta participates in tumor immunity, and it has been reported to inhibit carcinogenesis as well as growth of some tumors in vivo.

Details
Reactivity Human
Sample Volume 25 uL
Suitable Sample Types cell culture supernatant, serum, plasma (heparin, citrate)
Sensitivity 2.4 pg/mL
Standard Curve Range 27 - 20,000 pg/mL
Components 1 vial (175 ul) Fluorescent Beads (20x) coated with monoclonal antibody to human TNF-beta , Bead Population B10
2 vials human TNF-beta Standard (lyophilized): 400 ng/ml upon reconstitution
1 vial (350 ul) Biotin-Conjugate (20x) anti-human TNF-beta monoclonal antibody
Reported Applications Multiplex Immunoassay
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
BMS203* Human sTNF-R (60kDa) Platinum ELISA ELISA RUO
BMS221HS* Human IL-2 High Sensitivity ELISA ELISA RUO
BMS283INST* Human GM-CSF Instant ELISA ELISA RUO
BMS810FFRTU* Human Th1/Th2 11plex Ready-to-Use FlowCytomix Multiplex Multiplex RUO
BMS82001FF* Human G-CSF FlowCytomix Simplex Multiplex RUO
References

Citations: Giavedoni,L.D.. Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. Journal of Immunological Methods 2005;301:89-101. (Link)

Chudyk,A.; Masiuk,M.; Myslak,M.; Domanski,L.; Sienko,J.; Sulikowski,T.; Machalinski,B.; Giedrys-Kalemba,S.. Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition. Transplantation Proceedings 2006;38:90-93. (Link)

Rimoldi,Monica; Chieppa,Marcello; Salucci,Valentina; Avogadri,Francesca; Sonzogni,Angelica; Sampietro,Gianluca; Nespoli,Angelo; Viale,Giuseppe; Allavena,Paola; Rescigno,Maria. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-514. (Link)

Schmidt J,Welsch T,J„ger D,Mhlradt PF,Bchler MW,M„rten A.. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.. British Journal of Cancer 2007;97:598-604. (Link)

Veckman,V.; Julkunen,I.. Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells. J Leukoc.Biol 2008;83:296-304. (Link)

Catellani S,Poggi A,Bruzzone A,Dadati P,Ravetti JL,Gobbi M,Zocchi MR.. Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins. Blood 2007;109:2078-2085. (Link)

Raveney,B.J.; Richards,C.M.; Aknin,M.L.; Copland,D.A.; Burton,B.R.; Kerr,E.C.; Nicholson,L.B.; Williams,N.A.; Dick,A.D.. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established autoimmune uveoretinitis. Invest Ophthalmol.Vis.Sci. 2008;49:4008-4017. (Link)

Bonelli,Michael; Savitskaya,Anastasia; STEINER,CARL WALTER; Rath,Eva; Smolen,Josef S.; Scheinecker,Clemens. Phenotypic and Functional Analysis of CD4+CD25-Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus. The Journal of Immunology 2009;182:1689-1695. (Link)

Quiroga,Juan A.; Llorente,Silvia; Castillo,Inmaculada; Rodriguez-Inigo,Elena; Pardo,Margarita; Carreno,Vicente. Cellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the Liver. Journal of Virology 2006;80:10972-10979. (Link)

Yu,Tung Min; Chen,Yi Hsing; Hsu,Jeng Yuan; Sun,Chung Shu; Chuang,Ya Wen; Chen,Cheng Hsu; Wu,Ming Ju; Cheng,Chi Hung; Shu,Kuo Hsiung. Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis. Nephrology Dialysis Transplantation 2009;24:1946-1951. (Link)

Below,Sabine; Konkel,Anne; Zeeck,Cathrin; Muller,Christian; Kohler,Christian; Engelmann,Susanne; Hildebrandt,Jan Peter. Virulence factors of Staphylococcus aureus induce Erk-MAP kinase activation and c-Fos expression in S9 and 16HBE14o- human airway epithelial cells. Lung Cellular and Molecular Physiology 2009;296:L470-L479. (Link)

Makela,Sanna M.; Strengell,Mari; Pietila,Taija E.; Osterlund,Pamela; Julkunen,Ilkka. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. Journal of Leukocyte Biology 2009;85:664-672. (Link)

Braudeau,C.; Racape,M.; Giral,M.; Louis,S.; Moreau,A.; Berthelot,L.; Heslan,M.; shton-Chess,J.; Soulillou,J.P.; Brouard,S.. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl.Int 2007;20:845-855. (Link)

Munitz,Ariel; Bachelet,Ido; Eliashar,Ron; Moretta,Alessandro; Moretta,Lorenzo; Levi-Schaffer,Francesca. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006;107:1996-2003. (Link)

Siebert,J.C.; Inokuma,M.; Waid,D.M.; Pennock,N.D.; Vaitaitis,G.M.; Disis,M.L.; Dunne,J.F.; Wagner,D.H.,Jr.; Maecker,H.T.. An analytical workflow for investigating cytokine profiles. Cytometry A 2008;73:289-298. (Link)

Eixarch,Herena; Espejo,Carmen; Gomez,Alba; Mansilla,Maria Jose; Castillo,Mireia; Mildner,Alexander; Vidal,Francisco; Gimeno,Ramon; Prinz,Marco; Montalban,Xavier; Barquinero,Jordi. Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myeloablative Hematopoietic Gene Therapy With Autoantigen. Mol Ther 2009;17:897-905. (Link)

Kauss,Tina; Moynet,Daniel; Rambert,J; Al-Kharrat,Abir; Brajot,Stephane; Thiolat,Denis; Ennemany,Rachid; Fawaz,Fawaz;. Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis. Arthritis Research & Therapy 2008;10:R19(Link)

Elamin,R.D.ZeŠevi‘,D.Vojvodi‘,L.Medenica,and M.D.Pavlovi‘. Cytokine concentrations in basal cell carcinomas of different histological types and localization. Acta Dermatoven APA 2008;17:55-59. (Link)

Van Gulck,Ellen R.; Vanham,Guido; Heyndrickx,Leo; Coppens,Sandra; Vereecken,Katleen; Atkinson,Derek; Florence,Eric; Kint,Ilse; Berneman,Zwi Nisan; Tendeloo,Viggo Van. Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses by gag mRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals. Journal of Virology 2008;82:3561-3573. (Link)

Bermejo-Martin,J.F.; Bernardo,D.; Dominguez-Gil,M.; Alonso,A.; Garcia-Arevalo,M.C.; Pino,M.; de Lejarazu,R.O.; Eiros,J.M.; Ardura,J.; Leon,A.J.; Garrote,J.A.; Resino,S.; Blanco-Quiros,A.; Munoz-Fernandez,M.A.; Arranz,E.. Interleukin (IL)-1beta, IL-6 and IL-8 in nasal secretions: a common role for innate immunity in viral bronchial infection in infants?. Br J Biomed.Sci. 2006;63:173-175. (Link)

Rambert,Jerome; Mamani-Matsuda,Maria; Moynet,Daniel; Dubus,Pierre; Desplat,Vanessa; Kauss,Tina; Dehais,Jo; Schaeverbeke,Thierry; Ezzedine,Khaled; Malvy,Denis; Vincendeau,Philippe;. Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis. PLoS ONE 2009;4:(Link)

Chan Siu Lung,Anthony; Yip Chun-Hung,Eric; Yung Ying,Lisa; Pang,Haihong; Luk Chui-Wah,Sharon; Pang Fun,Shiu; Wong Hou,Yung. Immuno-regulatory effects of CKBM on the activities of mitogen-activated protein kinases and the release of cytokines in THP-1 monocytic cells.. Biol.Pharm.Bull. 2005;28:1645-1650. (Link)

Saadoun,D.; Rosenzwajg,M.; Landau,D.; Piette,J.C.; Klatzmann,D.; Cacoub,P.. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. Blood 2008;111:5334-5341. (Link)

Figueiredo,Constanca; Wittmann,Miriam; Wang,Dong; Dressel,Ralf; Seltsam,Axel; Blasczyk,Rainer; Eiz-Vesper,Britta. Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells. Blood 2009;113:3008-3016. (Link)

Yoshioka,M.; Fukuishi,N.; Kubo,Y.; Yamanobe,H.; Ohsaki,K.; Kawasoe,Y.; Murata,M.; Ishizumi,A.; Nishii,Y.; Matsui,N.; Akagi,M.. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol Pharm.Bull. 2008;31:212-216. (Link)

References: Li,C.B.; Gray,P.W.; Lin,P.F.; McGrath,K.M.; Ruddle,F.H.; Ruddle,N.H.. Cloning and expression of murine lymphotoxin cDNA. J.Immunol. 1987;138:4496-4501. (Link)

Bengtsson,A.K.; Ryan,E.J.. Immune function of the decoy receptor osteoprotegerin. Crit Rev.Immunol. 2002;22:201-215. (Link)

Spies,T.; Morton,C.C.; Nedospasov,S.A.; Fiers,W.; Pious,D.; Strominger,J.L.. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc.Natl.Acad.Sci.U.S.A 1986;83:8699-8702. (Link)

Scheurich,P.; Thoma,B.; Ucer,U.; Pfizenmaier,K.. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J.Immunol. 1987;138:1786-1790. (Link)

Gray,P.W.; Aggarwal,B.B.; Benton,C.V.; Bringman,T.S.; Henzel,W.J.; Jarrett,J.A.; Leung,D.W.; Moffat,B.; Ng,P.; Svedersky,L.P.; .. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 1984;312:721-724. (Link)

Vilcek,J.; Palombella,V.J.; Henriksen-DeStefano,D.; Swenson,C.; Feinman,R.; Hirai,M.; Tsujimoto,M.. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J.Exp.Med. 1986;163:632-643. (Link)

Adolf,G.R.; Apfler,I.. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids. J.Immunol.Methods 1991;143:127-136. (Link)

Paul,N.L.; Ruddle,N.H.. Lymphotoxin. Annu.Rev.Immunol. 1988;6:407-438. (Link)

Broudy,V.C.; Harlan,J.M.; Adamson,J.W.. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells. J.Immunol. 1987;138:4298-4302. (Link)

Adolf,G.R.; Lamche,H.R.. Highly sensitive enzyme immunoassay for human lymphotoxin (tumor necrosis factor beta) in serum. J.Immunol.Methods 1990;130:177-185. (Link)

Locksley,R.M.; Heinzel,F.P.; Shepard,H.M.; Agosti,J.; Eessalu,T.E.; Aggarwal,B.B.; Harlan,J.M.. Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells. J.Immunol. 1987;139:1891-1895. (Link)

Exley,A.R.; Cohen,J.. Optimal collection of blood samples for the measurement of tumor necrosis factor alpha. Cytokine 1990;2:353-356. (Link)

Wong,G.H.; Goeddel,D.V.. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 1986;323:819-822. (Link)

Himmler,A.; Maurer-Fogy,I.; Kronke,M.; Scheurich,P.; Pfizenmaier,K.; Lantz,M.; Olsson,I.; Hauptmann,R.; Stratowa,C.; Adolf,G.R.. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol. 1990;9:705-715. (Link)

Clark,I.A.; Gray,K.M.; Rockett,E.J.; Cowden,W.B.; Rockett,K.A.; Ferrante,A.; Aggarwal,B.B.. Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Trans.R.Soc.Trop.Med.Hyg. 1992;86:602-607. (Link)

Shalaby,M.R.; Aggarwal,B.B.; Rinderknecht,E.; Svedersky,L.P.; Finkle,B.S.; Palladino,M.A.,Jr.. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J.Immunol. 1985;135:2069-2073. (Link)

Kramer,S.M.; Carver,M.E.. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J.Immunol.Methods 1986;93:201-206. (Link)

Ishibashi,K.; Ishitsuka,K.; Chuman,Y.; Otsuka,M.; Kuwazuru,Y.; Iwahashi,M.; Utsunomiya,A.; Hanada,S.; Sakurami,T.; Arima,T.. Tumor necrosis factor-beta in the serum of adult T-cell leukemia with hypercalcemia. Blood 1991;77:2451-2455. (Link)

Bertolini,D.R.; Nedwin,G.E.; Bringman,T.S.; Smith,D.D.; Mundy,G.R.. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-518. (Link)


View More Products

AntigensArea of BiologyCell TypeFormats